Role of TNF-α in pulmonary host defense in murine invasive aspergillosis

Journal of Immunology

Volumn 162, Issue 3, 1999, Pages 1633-1640

  Mehrad, Borna ^a   Strieter, Robert M ^a   Standiford, Theodore J ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CYCLOPHOSPHAMIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FUNGUS IMMUNITY; IMMUNE RESPONSE; LUNG INJURY; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CHEMOKINES, CC; CHEMOKINES, CXC; CYCLOPHOSPHAMIDE; FEMALE; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG DISEASES, FUNGAL; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; NEUTROPENIA; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033084013     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Fraser, D. W., J. I. Ward, L. Ajello, and B. D. Plikaytis. 1979. Aspergillosis and other systemic mycoses: the growing problem. JAMA 242:1631.
2. Groll, A. H., P. M. Shah, C. Mentzel, M. Schneider, G. Jusl-Nuebling, and K. Huebner. 1996. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 33:23.
3. Bardana, E. J., Jr. 1981. The clinical spectrum of aspergillosis. II. Classification and description of saprophytic, allergic, and invasive variants of human disease. Crit. Rev. Clin. Lab. Sci. 13:85.
4. Denning, D. W. 1996. Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis. 23:608.
5. Schaffner, A., H. Douglas, and A. Braude. 1982. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest. 69:617.
6. Levitz, S. M., M. E. Selsted, T. Ganz, R. I. Lehrer, and R. D. Diamond. 1986. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J. Infect. Dis. 154:483.
7. Nessa, K., L. Palmberg, U. Johard, P. Malmberg, C. Jarstrand, and P. Camner. 1997. Reaction of human alveolar macrophages to exposure to Aspergillus fumigatus and inert particles. Environ. Res. 75:141.
8. Nessa, K., C. Jarstrand. A. Johansson, and P. Camner. 1997. In vitro interaction of alveolar macrophages and Aspergillus fumigatus. Environ. Res. 74:54.
9. Chilvers, E. R., C. L. Spreadbury, and J. Cohen. 1989. Bronchoalveolar lavage in an immunosuppressed rabbit model of invasive pulmonary aspergillosis. Mycopathologia 108:163.
10. Waldorf, A. R., S. M. Levitz, and R. D. Diamond. 1984. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J. Infect. Dis 150:752.
11. Roilides, E., A. Holmes, C. Blake, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1994. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-γ. J. Infect. Dis. 170:894.
12. Rex, J. H., J. E. Bennett, J. I. Gallin, H. L. Malech, and D. A. Melnick. 1990. Normal and deficient neulrophils can cooperate to damage Aspergillus fumigatus hyphae. J. Infect. Dis. 162:523.
13. Taramelli, D., M. G. Malabarba, G. Sala, N. Basilico, and G. Cocuzza. 1996. Production of cytokines by alveolar and peritoneal macrophages stimulated by Aspergillus fumigatus conidia or hyphae. J. Med. Vet. Mycol. 34:49.
14. Taramelli, D., M. G. Malabarba, N. Basilico, G. Sala, R. Mattina, and C. Cocuzza. 1994. Effects of pidotimod on macrophage functions in methylprednisolone-treated mice. Arzneimittelforschung 44:1425.
15. Grazziutti, M. L., J. H. Rex, R. E. Cowart, E. J. Anaissie, A. Ford, and C. A. Savary. 1997. Aspergillus fumigatus conidia induce a Th1-type cytokine response. J. Infect. Dis. 176:1579.
16. Gosselin, D., J. DeSanctis, M. Boule, E. Skamene, C. Matouk, and D. Radzioch. 1995. Role of tumor necrosis factor α in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect. Immun. 63:3272.
17. Laichalk, L. L., S. L. Kunkel, R. M. Strieter, J. M. Danforth, M. B. Bailie, and T. J. Standiford. 1996. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun. 64:5211.
18. Moussa, K., H. J. Michie, I. A. Cree, A. C. McCafferty, J. H. Winter, D. P. Dhillon, S. Stephens, and R. A. Brown. 1994. Phagocyte function and cytokine production in community acquired pneumonia. Thorax 49:107.
19. Nagai, H., J. Guo, H. Choi, and V. Kurup. 1995. Interferon-γ and tumor necrosis factor-α protect mice from invasive aspergillosis. J. Infect. Dis. 172:1554.
20. Kumaratilake, L. M., D. A. Rathjen, P. Mack, F. Widmer, V. Prasertsiriroj, and A. Ferrante. 1995. A synthetic tumor necrosis factor-α agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice. J. Clin. Invest. 95:2315.
21. Rathjen, D. A., A. Ferrante, and R Aston. 1993. Differential effects of small tumour necrosis factor-α peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity. Immunology 80:293.
22. Laichalk, L. L. K. A. Bucknell, G. B. Huffnagle, J. M. Wilkowski, T. A. Moore, R. J. Romanelli, and T. J. Standiford. 1998. Intrapulmonary delivery of tumor necrosis factor agonist peptide augments host defense in murine Gram-negative bacterial pneumonia. Infect. Immun. 66:2822.
23. Allen, S. D., K. N. Sorensen, M. J. Nejdl, C. Durrant, and R. T. Proffit. 1994. Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (fungizone) amphotericin B in murine pulmonary aspergillosis. J. Antimicrob. Chemother. 34:1001.
24. Lehmann, P. F., and L. O. White. 1975. Chilin assay used to demonstrate renal localization and cortisone-enhanced growth of Aspergillus fumigatus mycelium in mice. Infect. Immun 12:987.
25. Goldblum, S. E., K. M. Wu, and M. Jay. 1985. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J. Appl. Physiol. 59:1978.
26. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155:722.
27. Hunninghake, G. W., and A. S. Fauci. 1977. Immunological reactivity of the lung. IV. Effect of cyclophosphamide on alveolar macrophage cytotoxic effector function. Clin. Exp. Immunol. 27:555.
28. Cooper, J. A., Jr., W. W. Merrill, and H. Y. Reynolds. 1986. Cyclophosphamide modulation of bronchoalveolar cellular populations and macrophage oxidative metabolism: possible mechanisms of pulmonary pharmacotoxicity. Am. Rev. Respir. Dis. 134:108.
29. Gamble, J. R., J. M. Harlan, S. J. Klebanoff, and M. A. Vadas. 1985. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. USA 82:8667
30. Shahan, T. A., W. G. Sorenson, J. D. Paulauskis, R. Morey, and D. M. Lewis. 1998. Concentration- and time-dependent up regulation and release of the cytokines MIP-2, KC, TNF, and MIP-1α in rat alveolar macrophages by fungal spores implicated in airway inflammation. Am. J. Respir. Cell. Mol. Biol. 18:435.
31. Gao, J. L., T. A. Wynn, Y. Chang, E. J. Lee, H. E. Broxmeyer, S. Cooper, H. L. Tiffany, H. Westphal, J. Kwon-Churg, and P. M. Murphy. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185:1959.